Literature DB >> 6311415

Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.

M T Bakowski, J C Crouch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6311415     DOI： 10.1016/0305-7372(83)90030-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  28 in total

1.  Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.

Authors:  F Nomura; K Shimokata; H Saito; S Sakai; A Watanabe; H Saka
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer.

Authors:  M J Lind; S Gomm; A P Simmonds; L Ashcroft; A Kamthan; H Gurney; N Thatcher
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

Authors:  N Niederle; J Ostermann; W Achterrath; L Lenaz; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

Authors:  J H Kearsley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

5.  Ifosfamide by bolus as treatment for advanced non-small cell lung cancer.

Authors:  N Thatcher; H Anderson; D B Smith; W P Steward; K Webb; A Hilton; A Rahman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Authors:  P Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Phase I study of high-dose cisplatin, ifosfamide, and etoposide.

Authors:  E A Perez; P C Sowray; S L Gardner; D R Gandara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.

Authors:  R Stuart-Harris; R M Fox; D Raghavan; A S Coates; D Hedley; J A Levi; R L Woods; M H Tattersall
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

9.  Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer.

Authors:  R L Souhami; R M Rudd; S G Spiro; R Allen; P Lamond; P G Harper
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer.

Authors:  H Saito; K Shimokata; M Yamamoto; H Saka; S Sakai; H Saito
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.